Cargando…
Reduced Prescription of Baloxavir After Suspected Prevalence of a Baloxavir-Resistant Influenza Virus Strain and the Emergence of SARS-CoV-2 in a Tertiary Hospital in Japan
OBJECTIVE: The use of baloxavir, a new anti-influenza agent, began in Japan from the 2018 to 2019 season and became the focus of attention due to its efficient viral reduction ability; therefore, we should know the prescription changes of anti-influenza agents. METHODS: We analyzed the changes in th...
Autores principales: | Kamioka, Yasuhiro, Kashiwagura, Shota, Seki, Masafumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457847/ https://www.ncbi.nlm.nih.gov/pubmed/32922095 http://dx.doi.org/10.2147/CPAA.S268666 |
Ejemplares similares
-
Modeling mitigation of influenza epidemics by baloxavir
por: Du, Zhanwei, et al.
Publicado: (2020) -
Prescription factors influencing baloxavir prescription during the 2018/2019 and 2019/2020 seasons: a administrative database study in Japan
por: Fujiwara, Naomi, et al.
Publicado: (2023) -
Efficacy of baloxavir marboxil on household transmission of influenza infection
por: Umemura, Takumi, et al.
Publicado: (2020) -
Baloxavir Marboxil: An Original New Drug against Influenza
por: Dufrasne, François
Publicado: (2021) -
Analysis of Risk Factors Associated with Reduced Trough Concentrations of Vancomycin in Relation to Renal Function in a Tertiary Hospital in Japan
por: Kashiwagura, Shota, et al.
Publicado: (2021)